Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A ProSpective, MulticEnter, Concurrently Controlled Clinical Study of Chondro-Gide® ArticUlar Cartilage CoveR for the Treatment of Large Chondral Lesions in the KnEe (SECURE)

NCT04537013 is registered in ClinicalTrials.gov with Geistlich Pharma AG as lead sponsor.

NCT NCT04537013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A ProSpective, MulticEnter, Concurrently Controlled Clinical Study of Chondro-Gide® ArticUlar Cartilage CoveR for the Treatment of Large Chondral Lesions in the KnEe (SECURE)
Lead sponsor
Geistlich Pharma AG
Phase
Not applicable
Overall status
Terminated
Start date
August 26, 2020
Completion date
September 29, 2025
Enrollment
82 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage disease, cartilage injury, knee discomfort, knee injuries